Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ShalbyNSE:SHALBY -0.96%83 3-1 Month Momentum % is -7.89% as of Sep. 08, 2026. GuruFocus rates NSE:SHALBY with a GF Score™ of 83/100 and a GF Value™ of ₹263.68 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Shalby ranks worse than 75.23% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-08), Shalby's 3-1 Month Momentum % is -7.89%.
The industry rank for Shalby's 3-1 Month Momentum % or its related term are showing as below:
NSE:SHALBY's 3-1 Month Momentum % is ranked worse than 75.23% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 0.405
vs NSE:SHALBY: -7.89
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Shalby 3-1 Month Momentum % Related Terms
NSE:SHALBY vs HCA, THC, EHC: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Shalby's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shalby 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Shalby's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Shalby's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shalby (NSE:SHALBY) has a 3-1 Month Momentum % of -7.89% as of Sep. 08, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Shalby and its competitors. According to the industry distribution chart, Shalby ranks #501 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 75.2%.
Is Shalby's 3-1 Month Momentum % too high?
Shalby's current 3-1 Month Momentum % is -7.89%. Based on the distribution chart, Shalby ranks #501 out of 666 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Shalby has a GF Score™ of 83/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shalby's 3-1 Month Momentum % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Shalby ranks #501 out of 666 companies for 3-1 Month Momentum %. This places Shalby in the lower half of its industry. The industry median 3-1 Month Momentum % is 0.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
The median 3-1 Month Momentum % among Healthcare Providers & Services companies is 0.41, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Shalby and its competitors. For the Healthcare Providers & Services industry, the median 3-1 Month Momentum % is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shalby's current 3-1 Month Momentum % is -7.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shalby stock overvalued right now?
Based on GuruFocus' analysis, Shalby (NSE:SHALBY) is currently considered Possible Value Trap. The stock's GF Value™ is ₹263.68, compared to a current price of ₹151.24 — trading 42.6% below its estimated fair value. The current 3-1 Month Momentum % is -7.89%. Shalby's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Shalby (NSE:SHALBY), the current 3-1 Month Momentum % is -7.89% as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shalby (NSE:SHALBY) Overvalued in 2026?
Based on GuruFocus' analysis, Shalby stock appears to be undervalued.
The current stock price of ₹151.24 is trading 42.6% below its estimated GF Value™ of ₹263.68.
GuruFocus considers Shalby to be Possible Value Trap.
Key valuation signals for NSE:SHALBY:
3-1 Month Momentum %: -7.89%
GF Value™: ₹263.68 vs. price of ₹151.24 (42.6% below fair value)
No single metric tells the full story. See the NSE:SHALBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shalby Ltd operates a chain of multispecialty hospitals. It is engaged in setting up and managing hospitals and medical diagnostic services. The hospitals offer healthcare services to patients in various areas of specialization such as Cardiology, Emergency Medicine, Gastroenterology Surgery, Arthroscopy Sports Injury, Infectious Diseases, Oncology, and others. The activities are mainly conducted only in India. Revenue mainly comprises fees charged for inpatient and outpatient hospital services. Services include charges for accommodation, medical professional services, equipment, radiology, laboratory, and pharmaceutical goods used in treatments given to Patients.
83GF Score
Get the complete analysis for NSE:SHALBY
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SHALBY has been successfully added to your 
